BLOOMFIELD, Conn., April 15, 2026 /PRNewswire/ — Arxis, Inc. (“Arxis”), a portfolio company of Arcline Investment Management and a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical engineered components, announced today the pricing of its upsized initial public offering of 40,500,000 shares of Class A common stock (the “Shares”), offered by Arxis at a public offering price of $28.00 per share. In addition, Arxis has granted the underwriters a 30-day option to purchase up to 6,075,000 additional shares at the public offering price, less underwriting discounts and commissions. The Shares are expected to begin trading on the Nasdaq Global Select Market on April 16, 2026, under the symbol “ARXS.”
The closing of the offering is expected to occur on April 17, 2026, subject to the satisfaction of customary closing conditions.
Goldman Sachs & Co. LLC, Morgan Stanley and Jefferies are acting as lead joint book-running managers for the offering.
Citigroup and RBC Capital Markets are acting as joint book-running managers, and Baird, Guggenheim Securities, Wells Fargo Securities, William Blair, Rothschild & Co, and Wolfe | Nomura Alliance are acting as book-running managers.
Citizens Capital Markets is acting as a co-manager.
A registration statement on Form S-1 relating to the offering has been filed with the U.S. Securities and Exchange Commission (the “SEC”) and was declared effective on April 15, 2026. The offering is being made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, copies of the prospectus may be obtained from Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at 866-471-2526 or by email at prospectus-ny@ny.email.gs.com; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; or Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, New York 10022, by telephone at (877) 821-7388 or by email at Prospectus_Department@Jefferies.com.
This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.
“Wolfe | Nomura Alliance” is the marketing name used by Wolfe Research Securities and Nomura Securities International, Inc. in connection with certain equity capital markets activities conducted jointly by the firms. Both Nomura Securities International, Inc. and WR Securities, LLC are serving as underwriters in the offering described herein. In addition, WR Securities, LLC and certain of its affiliates may provide sales support services, investor feedback, investor education, and/or other independent equity research services in connection with this offering.
About Arxis
Arxis is a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components for aerospace and defense, medical technology, and specialized industrial markets. Leveraging significant intellectual property and world-class engineering and operational capabilities, Arxis designs and delivers innovative solutions that address our customers’ most complex performance needs.
Media Contacts
Kate Thompson / Tim Ragones / Alexander Wolfsohn
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449
View original content:https://www.prnewswire.com/news-releases/arcline-backed-arxis-announces-pricing-of-its-initial-public-offering-302743924.html
SOURCE Arxis
Disclaimer: The above press release comes to you under an arrangement with PR Newswire. We takes no editorial responsibility for the same.